Oraverse (Phentolamine Mesilate)

Phentolamine mesylate, the active ingredient in Oraverse, is an alpha‑2 antagonist presented as a 0.5 mg/mL solution for intravenous use. It is employed to manage vascular complications such as ischemia and to facilitate certain diagnostic procedures.

GNH USA supplies Oraverse as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Oraverse is an alpha‑2 blocking agent that acts on the vascular system to improve blood flow in several clinical settings. - Peripheral arterial spasm: Relieves the spasm and restores perfusion in distal limb ischemia. - Coronary artery spasm during angiography or angioplasty : Allev Al  "); -   g ",

Common